Melanoma Advanced
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma. (NCT07686835) | Radboud University Medical Center | 2026-07-31 |
| RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma (NCT07445022) | Fudan University | 2026-01-28 |
| Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy. (NCT06784778) | Pamgene International B.V. | 2024-07-12 |
| A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma (NCT05732805) | Biocad | 2022-08-02 |
Track Melanoma Advanced automatically
Every clearance here is in the API, with alerts when new ones post.